The CTTI Steering Committee, made up of representatives from CTTI members across multiple sectors, provides input into decisions about CTTI priorities, projects and recommendations. Below is a list of our current Steering Committee members.
Jeff Allen
President & CEO
Friends of Cancer Research
Maria Apostolaros
Deputy Vice President, Science & Regulatory Advocacy
PhRMA
Marianna Azar
Policy Lead
1Day Sooner
Ella Balasa
Patient Representative
Steve Berman
Senior Director, Science & Regulatory Affairs
Biotechnology Innovation Organization
Susan Bersoff-Matcha
Director, Office of Clinical Policy
Food and Drug Administration/Office of the Commissioner
Kousick Biswas
Director, CSPCC
U.S. Department of Veterans Affairs
Denise Bonds
Senior Clinical Program Officer
Patient-Centered Outcomes Research Institute (PCORI)
Barbara Braffett
George Washington University, Assistant Research Professor
Representing Society for Clinical Trials (SCT)
Christina Brennan *
Vice President, Clinical Research
Northwell Health
Kevin Bugin
Head of Global Regulatory Policy and Intelligence
Amgen
Kathryn Capanna
Deputy Division Director, Office of Strategic Programs & Technology Innovation, DARSS
Food and Drug Administration/Center for Devices and Radiological Health (CDRH)
Wendy Carr
Branch Chief, Clinical Research Branch
Centers for Disease Control and Prevention
Carol Chapman
Director of Community Impact
Crohn's & Colitis Foundation
Marianne Chase
Senior Director of Clinical Trials Operations
Neurological Clinical Research Institute of Massachusetts General Hospital
Sydney Cobb
Director, Clinical Operations
Lindus Health
Caroline Donovan
Director of Patient Engagement
Lupus Research Alliance
Samantha Eells
Solutions and Market Lead – Pharma – Clinical Development/Clinical Operations
TriNetX
Rasmus Enggaard
Therapy Area Head, Cardio-Renal, Liver & Rare Diseases
Novo Nordisk
Virginia Fitt
General Council and Compliance Officer
Care Access Research
Pat Furlong
President
Parent Project Muscular Dystrophy (PPMD)
Dale Gamble
Operations Administrator
Mayo Clinic
Shruti Gohil
Associate Medical Director, Hospital Epidemiology
University of California, Irvine
Jörg Goldhahn
Medical Director at ETH and Director of Institute for Translational Medicine
ETH Zurich | Institute of Translational Medicine
Catherine Gregor
Chief Clinical Trial Officer
Florence Healthcare
Dave Hanaman
President & Co-Founder
Curavit
Sam Hariry
Global Head, Clinical Innovation, NIBR Translational Medicine
Novartis Institutes for Biomedical Research
Raffaella Hart
Senior VP, IRB, IBC, and QA Services
CITI Program, a Division of BRANY
James Holahan
Director, Clinical Research Support
New York University Langone Medical Center
Christopher Houchens
Director Division of CBRN Countermeasures
Biomedical Advanced Research and Development Authority
Sameera Ibrahim
Head, R&D Quality Strategy & Business Operations at Bristol Myers Squibb
Bristol Myers Squibb
Rasika Kalamegham
Head, US Regulatory Policy
Genentech – a member of the Roche Group
Rachana Kanvinde
Director, SPARK CoE, Clinical Trial Access & Partnerships
Tigerlily Foundation
Jason Kim
Vice President, Osteoarthritis Research
Arthritis Foundation
Natalie Klein
Director, Division of Policy and Assurances
Office for Human Research Protections (OHRP)
Luke Laffin
Co-Director, Center for Blood Pressure Disorders Cardiovascular Medicine
Cleveland Clinic Coordinating Center for Clinical Research (C5Research)
Martin Landray
Professor of Medicine & Epidemiology, Deputy Director - Big Data Institute
University of Oxford
Anne Lawrence
Vice President, Global Monitoring & Site Engagement
GlaxoSmithKline
Patrick Lee
Partner
Palo Alto Investors Inc.
Laura Levit
Senior Director, Research Analysis and Publications
American Society of Clinical Oncology (ASCO)
Elizabeth Luczak
VP Global QMS and Compliance
Vertex Pharmaceuticals
Andrea McSweeney
Senior Customer Success Lead
Medable
Mary Anne Meskis
Executive Director
Dravet Syndrome Foundation
Jennifer Miller
Associate Professor
Yale
Kristen Miller
Health Science Policy Analyst, OMP
Food and Drug Administration/Center for Drug Evaluation and Research (CDER)
Ken Newman
Senior Vice President, Clinical Development
Ionis Pharmaceuticals
David Nickerson
Head, Clinical Quality Management
EMD Serono Inc.
Kim O'Day
Senior Director, Emerging Technology Operations
Eli Lilly and Company
Megan O'Neil
Patient Representative
Julie Ozier
SVP for IRB Review and Advarra's Institutional Official
Advarra
Daniel Park
Strategic Partnerships
CareEvolution
Donna Parker
Director, i-Cubed Center for Clinical Research Innovation
Duke University
Michael Pierre
Project Manager
Society for Clinical Research Sites
Lynne Quittell
Vice Chair Data Safety Monitoring Board
Cystic Fibrosis Foundation
Michelle Rowe
VP of Operations
HCA Healthcare
Kristin Schneeman
Director of Programs
FasterCures, of the Milken Institute
John Scott
Director, Division of Biostatics
Food and Drug Administration/Center for Biologics Evaluation and Research (CBER)
Jessica Shore
Vice President, Clinical Affairs and Quality
Pulmonary Fibrosis Foundations
Donna Snyder
Executive Physician
WIRB-Copernicus Group
Barry Stein
President, CEO
Colorectal Cancer Canada
Evelyn Stevens
Senior Director, Community Engagement
Parkinson's Foundation
Theresa Strong
Director of Research Programs
Foundation for Prader-Willi Research (FPWR)
Maria Vassileva
Global Head of Science and Scientific Strategy
Representing Drug Information Association (DIA)
David Vulcano
CEO
The Association of Clinical Research Professionals (ACRP)
Salina Waddy
Associate Director and Chief, CTSA Program Clinical Affairs
National Institutes of Health
Meghan Wagner
Health Scientist, Pharmacy Outcomes Research
Agency for Healthcare Research and Quality (AHRQ)
Henry Wei
Head of Development Innovation
Regeneron Pharmaceuticals
Neil Weissman
President, Chief Scientific Officer
MedStar Health
Tiffany Westrich-Robertson
CEO, Director of Patient Engagement
AiArthritis
Glendon Zinser
Sr. Director, Scientific Strategy & Programs
Susan G Komen
*Current Steering Committee liaison to the CTTI Executive Committee